Simple test at birth saves baby from ravaging disease

Simple test at birth saves baby from ravaging disease

Source: KOMO News

Two babies in our state were born with an immune system disorder, within months of each other. One died after simply catching a cold. The other is thriving today, thanks to a simple difference. He was born after state-mandated testing for the disease. With early detection, doctors were able to save his life. The ordeal started mysteriously for the baby's parents. When Ezra Dixon made his debut on April 7, 2014, he seemed perfect. But as the Dixons celebrated, a tiny drop of Ezra's blood was in a lab, undergoing the newborn screening test every child in the state receives.

About Seattle Children’s

Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.

Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation’s top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research. Join Seattle Children’s bold initiative – It Starts With Yes: The Campaign for Seattle Children’s – to transform children’s health for generations to come.

For more information, visit or follow us on Twitter, Facebook, Instagram or on our On the Pulse blog.